Grace Therapeutics
GRCE
9 hedge funds and large institutions have $53.1K invested in Grace Therapeutics in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 5 closing their positions.
0.01% less ownership
Funds ownership: 0.05% → 0.03% (-0.01%)
25% less funds holding
Funds holding: 12 → 9 (-3)
53% less capital invested
Capital invested by funds: $112K → $53.1K (-$59.1K)
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$19.9K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$14.6K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$582 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$22K |
| 2 |
VF
Virtu Financial
New York
|
-$17K |
| 3 |
National Bank of Canada
Montreal,
Quebec, Canada
|
-$12.4K |
| 4 |
TSS
Two Sigma Securities
New York
|
-$7.03K |
| 5 |
Morgan Stanley
New York
|
-$6.05K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $14K | +$19.9K | +4,048 | New |
|
|
TSS
2
Two Sigma Securities
New York
| $10K | -$7.03K | -1,426 | -34% |
|
3
Geode Capital Management
Boston,
Massachusetts
| $10K | – | – | – |
|
|
4
Citadel Advisors
Miami,
Florida
| $10K | +$14.6K | +2,971 | New |
|
|
5
Morgan Stanley
New York
| $6K | -$6.05K | -1,228 | -39% |
|
|
6
National Bank of Canada
Montreal,
Quebec, Canada
| $2K | -$12.4K | -2,521 | -82% |
|
|
7
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | +$582 | +118 | +179% |
|
|
FDCDDQ
8
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $101 | -$34 | -7 | -18% |
|
|
TWC
9
TD Waterhouse Canada
Toronto,
Ontario, Canada
| $3 | – | – | – |
|
|
10
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$22K | -4,327 | Closed |
|
|
VF
11
Virtu Financial
New York
| – | -$17K | -3,286 | Closed |
|
|
SIAP
12
Sterling Investment Advisors (Pennsylvania)
Berwyn,
Pennsylvania
| – | -$4K | -833 | Closed |
|
GRCE Hedge Fund Activity: Q3 2022 in Review
9 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Grace Therapeutics (GRCE) for Q3 2022, worth a combined $53.1K — down 53% from $112K a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of GRCE and 2 opened new positions — a net loss of 3 holders — while 4 trimmed existing stakes and 1 added.
The largest buyer was UBS Group, opening a new position worth an estimated $19.9K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $22K sold.
- 9 institutional investors held Grace Therapeutics (GRCE) as of Q3 2022, down from 12 in Q2 2022.
- Funds reported $53.1K of Grace Therapeutics stock for Q3 2022, down 53% quarter-over-quarter.
- 2 funds opened new Grace Therapeutics positions in Q3 2022 and 5 closed out, a net change of -3 holders.
- The largest Grace Therapeutics buyer in Q3 2022 was UBS Group, an estimated $19.9K added.
- The largest Grace Therapeutics seller in Q3 2022 was Susquehanna International Group, an estimated $22K sold.
Based on aggregated 13F filings for Q3 2022.